TraceR2CFramework library / GMP · 21 CFR 211
Pharma & Life Sciences · regulatory framework
cGMP — 21 CFR Part 211 for Finished Pharmaceuticals.
FDA’s current Good Manufacturing Practice: every component, supplier and test result documented and defensible.
What it is
21 CFR Part 211 sets the FDA’s current Good Manufacturing Practice requirements for finished pharmaceuticals. Subpart E governs control of components: each lot must be tested or validated against specifications, suppliers must be qualified with ongoing oversight, and records must make every quality decision reconstructable.
Who it applies to
Pharmaceutical and nutraceutical manufacturers, contract manufacturers (CMOs/CDMOs), and their component and API suppliers.
The evidence auditors expect
- Supplier qualification records with periodic re-evaluation
- Specifications and test methods for every component
- COAs for each lot, with your reliance on them validated
- Deviation and CAPA records tied to affected lots and suppliers
- Complete batch records with review and disposition decisions
How ComplianceFlow keeps you ready
- Supplier qualification documents are collected, tracked and re-requested on schedule — with the full history retained
- COA values are extracted and checked against specifications, with human review captured for every disposition
- The requirement → evidence → reviewer → decision chain is permanent, exactly what an FDA investigator reconstructs
Related frameworks
See GMP · 21 CFR 211 evidence assemble itself.
ComplianceFlow keeps a living copy of GMP · 21 CFR 211 mapped to your suppliers, products and evidence — so what you must prove is always current, and always exportable.
Book a demo Get the audit checklist